Nanosphere Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Nanosphere Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013635
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Its verigene system is used to identify and treat the bacteria and viruses. Nanosphere offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company’s cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US.

Nanosphere Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanosphere Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Nanosphere Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanosphere Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Nanosphere Raises USD10 Million in Public Offering of Shares 11
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Acquisition 15
Luminex Acquires Nanosphere in Tender Offer 15
Nanosphere Inc – Key Competitors 17
Nanosphere Inc – Key Employees 18
Nanosphere Inc – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
May 16, 2016: Nanosphere Announces First Quarter Results 20
Feb 24, 2016: Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Nanosphere Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Nanosphere Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Nanosphere Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Nanosphere Inc, Medical Devices Deals, 2011 to YTD 2017 9
Nanosphere Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Nanosphere Raises USD10 Million in Public Offering of Shares 11
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 13
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 14
Luminex Acquires Nanosphere in Tender Offer 15
Nanosphere Inc, Key Competitors 17
Nanosphere Inc, Key Employees 18

★海外企業調査レポート[Nanosphere Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innate Immunotherapeutics Ltd (IIL)-製薬・医療分野:企業M&A・提携分析
    Summary Innate Immunotherapeutics Ltd (Innate Immunotherapeutics), formerly Innate Therapeutics Ltd is a medical biotechnology company that develops therapeutic drugs for the treatment of cancer and infectious diseases. The company designs and develops immunomodulator microparticle technology. Innat …
  • Petoro AS:企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Bravura Solutions Limited (BVA):企業の財務・戦略的SWOT分析
    Bravura Solutions Limited (BVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Naspers Limited:企業のM&A・事業提携・投資動向
    Naspers Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Naspers Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Castle Brands Inc.:企業の戦略・SWOT・財務情報
    Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report Summary Castle Brands Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mindray Medical International Limited:企業の戦略・SWOT・財務分析
    Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report Summary Mindray Medical International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • The Whiting-Turner Contracting Co:企業の戦略・SWOT・財務情報
    The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report Summary The Whiting-Turner Contracting Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Berjaya Corporation Berhad (BJCORP):企業の財務・戦略的SWOT分析
    Berjaya Corporation Berhad (BJCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • JRI Orthopaedics Ltd:製品パイプライン分析
    Summary JRI Orthopaedics Ltd (JRI), a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides custom …
  • Glencore Plc:企業の戦略・SWOT・財務情報
    Glencore Plc - Strategy, SWOT and Corporate Finance Report Summary Glencore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Oldenburgische Landesbank AG:企業の戦略・SWOT・財務分析
    Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Qatargas Operating Co Ltd:企業の戦略的SWOT分析
    Qatargas Operating Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Centene Corp (CNC):企業の財務・戦略的SWOT分析
    Centene Corp (CNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Lion Energy Ltd (LIO):石油・ガス:M&Aディール及び事業提携情報
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Pfizer Inc.:戦略・SWOT・企業財務分析
    Pfizer Inc. - Strategy, SWOT and Corporate Finance Report Summary Pfizer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Biotest AG (BIO):企業の財務・戦略的SWOT分析
    Biotest AG (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Pivotal Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pivotal Therapeutics Inc (Pivotal Therapeutics) is a pharmaceutical company that develops and markets Omega-3 based therapies and therapeutic products for cardiovascular disorders. The company offers products such as VASCAZEN, a medical food formulated for the dietary management of an Omega- …
  • Clean Harbors, Inc. (CLH)-石油・ガス分野:企業M&A・提携分析
    Summary Clean Harbors, Inc. (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and insit …
  • One Lambda Inc:医療機器:M&Aディール及び事業提携情報
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device manufacturing company that offers laboratory products. The company develops and distributes antibody detection products and histocompatibility typing tests. Its products include HLA testing reagents …
  • Daito Trust Construction Co., Ltd.:企業の戦略・SWOT・財務分析
    Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daito Trust Construction Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆